397 related articles for article (PubMed ID: 36778122)
1. Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy.
Yu Y; Yu J; Ge S; Su Y; Fan X
Int J Biol Sci; 2023; 19(3):811-828. PubMed ID: 36778122
[TBL] [Abstract][Full Text] [Related]
2. Lysosomes contribute to radioresistance in cancer.
Zhang X; Wang J; Li X; Wang D
Cancer Lett; 2018 Dec; 439():39-46. PubMed ID: 30217567
[TBL] [Abstract][Full Text] [Related]
3. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
[TBL] [Abstract][Full Text] [Related]
4. Role of metabolism in cancer cell radioresistance and radiosensitization methods.
Tang L; Wei F; Wu Y; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Deng H; Cao K; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):87. PubMed ID: 29688867
[TBL] [Abstract][Full Text] [Related]
5. DNA repair inhibitors to enhance radiotherapy: Progresses and limitations.
Ferreira S; Dutreix M
Cancer Radiother; 2019 Dec; 23(8):883-890. PubMed ID: 31615730
[TBL] [Abstract][Full Text] [Related]
6. Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer.
Post AEM; Bussink J; Sweep FCGJ; Span PN
Oncol Res; 2020 Feb; 28(1):33-40. PubMed ID: 31046897
[TBL] [Abstract][Full Text] [Related]
7. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.
Jain SM; Nagainallur Ravichandran S; Murali Kumar M; Banerjee A; Sun-Zhang A; Zhang H; Pathak R; Sun XF; Pathak S
Cancer Biol Ther; 2024 Dec; 25(1):2317999. PubMed ID: 38445632
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the epigenetic network in cancer radioresistance.
Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
[TBL] [Abstract][Full Text] [Related]
10. Autophagy-regulating microRNAs: potential targets for improving radiotherapy.
Li H; Jin X; Chen B; Li P; Li Q
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1623-1634. PubMed ID: 29971533
[TBL] [Abstract][Full Text] [Related]
11. Dual Targeting of DNA Damage Response Proteins Implicated in Cancer Radioresistance.
Vasilopoulos SN; Güner H; Uça Apaydın M; Pavlopoulou A; Georgakilas AG
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137049
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
Fanale D; Castiglia M; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
[TBL] [Abstract][Full Text] [Related]
13. Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy.
Zaffaroni M; Vincini MG; Corrao G; Marvaso G; Pepa M; Viglietto G; Amodio N; Jereczek-Fossa BA
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232638
[TBL] [Abstract][Full Text] [Related]
14. The roles of glucose metabolic reprogramming in chemo- and radio-resistance.
Lin J; Xia L; Liang J; Han Y; Wang H; Oyang L; Tan S; Tian Y; Rao S; Chen X; Tang Y; Su M; Luo X; Wang Y; Wang H; Zhou Y; Liao Q
J Exp Clin Cancer Res; 2019 May; 38(1):218. PubMed ID: 31122265
[TBL] [Abstract][Full Text] [Related]
15. Pim-3 contributes to radioresistance through regulation of the cell cycle and DNA damage repair in pancreatic cancer cells.
Chen XY; Wang Z; Li B; Zhang YJ; Li YY
Biochem Biophys Res Commun; 2016 Apr; 473(1):296-302. PubMed ID: 27016481
[TBL] [Abstract][Full Text] [Related]
16. Genetic variations in DNA repair genes, radiosensitivity to cancer and susceptibility to acute tissue reactions in radiotherapy-treated cancer patients.
Chistiakov DA; Voronova NV; Chistiakov PA
Acta Oncol; 2008; 47(5):809-24. PubMed ID: 18568480
[TBL] [Abstract][Full Text] [Related]
17. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression.
Shimura T; Kakuda S; Ochiai Y; Nakagawa H; Kuwahara Y; Takai Y; Kobayashi J; Komatsu K; Fukumoto M
Oncogene; 2010 Aug; 29(34):4826-37. PubMed ID: 20562919
[TBL] [Abstract][Full Text] [Related]
18. Feedback loop between hypoxia and energy metabolic reprogramming aggravates the radioresistance of cancer cells.
Shi Z; Hu C; Zheng X; Sun C; Li Q
Exp Hematol Oncol; 2024 May; 13(1):55. PubMed ID: 38778409
[TBL] [Abstract][Full Text] [Related]
19. Nrf2 is a potential therapeutic target in radioresistance in human cancer.
Zhou S; Ye W; Shao Q; Zhang M; Liang J
Crit Rev Oncol Hematol; 2013 Dec; 88(3):706-15. PubMed ID: 24126138
[TBL] [Abstract][Full Text] [Related]
20. Emerging strategies to target cancer metabolism and improve radiation therapy outcomes.
Kery M; Papandreou I
Br J Radiol; 2020 Nov; 93(1115):20200067. PubMed ID: 32462882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
